Indians who have received double doses (fully vaccinated) of Covaxin and the associated Covid-19 certificate will be exempted from a pre-departure Covid-19 test.
Earlier this month, the Hyderabad-based Bharat Biotech had submitted the trial data of the Phase-2 and Phase-3 trials of Covaxin on children to the DCGI